首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1819731

2021-2031年亞太地區解剖病理學市場報告（範圍、細分、動態和競爭分析）

Asia Pacific Anatomic Pathology Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年07月10日 | 出版商:

The Insight Partners | 英文 135 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

解剖病理學市場預計將大幅成長，到 2031 年將達到 140.3208 億美元，高於 2023 年的 72.5284 億美元。這一成長代表著 2023 年至 2031 年的年複合成長率(CAGR) 為 8.6%。

執行摘要和亞太解剖病理學市場概覽

在亞太地區，解剖病理學市場的主要參與者包括中國、日本、印度、澳洲和韓國，並對該地區其他國家進行了深入分析。該地區解剖病理學市場的成長主要得益於慢性病盛行率的上升以及數位化解決方案和先進病理學工具的普及。澳洲和韓國等國家由於其醫療保健系統的不斷發展，預計將帶來巨大的成長機會。

市場區隔分析

亞太地區解剖病理學市場可以根據產品和服務、應用和最終用戶進行細分。

1. 產品和服務：此部分包括服務、儀器和耗材。 2023年，儀器佔據了最大的市場。服務部分進一步細分為組織病理學和細胞病理學，而儀器部分包括切片機、低溫恆溫器、自動染色機、組織處理機和其他相關工具。

2. 應用：市場分為疾病診斷、藥物發現及開發等。疾病診斷領域在2023年佔據最大佔有率，反映了解剖病理學在識別各種健康狀況方面的關鍵作用。

3. 最終使用者：此部分包括醫院、研究實驗室、診斷實驗室等。醫院在2023年佔據了最大的市場佔有率，凸顯了其在利用解剖病理學服務方面的核心作用。

亞太解剖病理學市場展望

數位病理學是解剖病理學領域的一個新興領域，它利用數位技術來增強資料收集和管理流程。這項創新最大限度地降低了標本處理的風險，並有可能加快臨床試驗的患者入組速度。此外，數位病理學可以顯著縮短從樣本採集到結果的周轉時間，從而簡化中央病理學審查流程，提高試驗效率。

機器學習 (ML) 和人工智慧 (AI) 與數位病理學的融合，正在透過增強資料分析和管理能力，徹底改變該領域。許多解剖病理學實驗室越來越認知到數位化和人工智慧的優勢，它們有望提高診斷的準確性、效率和一致性。近期的技術進步和法規核准正在進一步推動實驗室營運的數位化。

2023年11月，Dedalus Group 和 Ibex Medical Analytics 推出了一個基於人工智慧的全面數位病理學解決方案，旨在用於癌症診斷。該解決方案透過下一代解剖病理學資訊系統 (AIS) 和數位病理學解決方案，促進解剖病理學實驗室的全面數位化，利用資料和人工智慧來改善病例優先排序、進階影像分析和一致性診斷。解剖病理學流程中對人工智慧整合的日益重視，預計將成為未來幾年推動市場成長的重要趨勢。

亞太解剖病理學市場的國家洞察

亞太解剖病理學市場涵蓋中國、日本、印度、澳洲、韓國等國。 2023年，中國佔最大市場佔有率。癌症已成為中國的主要公共衛生問題。世界衛生組織 (WHO) 報告稱，2020年中國新增癌症病例457萬例，癌症相關死亡人數300萬例，均為全球最高。這一令人擔憂的趨勢促使人們更加重視早期癌症篩檢、診斷和治療。

近二十年來，中國政府實施了「農村癌症篩檢計畫」、「農村婦女子宮頸癌和乳癌篩檢計畫」等多項大規模癌症篩檢計劃，顯著提高了全民各類癌症的篩檢率，為基層醫療衛生機構做好癌症防治工作做出了貢獻。

此外，中國正在從傳統的病理診斷方法轉型為數位病理學。根據上海數位醫學創新中心2022年的報告，約40%的受訪醫院正在開發或已經建立了數位病理系統。許多醫院已在這些系統上投入了大量資金，顯示其致力於提升診斷能力。報告也指出，2022年約有23%的遠距臨床會診使用了數位病理學，反映出其在醫療保健領域日益成長的重要性。

亞太解剖病理學市場的關鍵參與者

解剖病理學市場的知名公司包括羅氏公司 (F. Hoffmann-La Roche Ltd)、貝克曼庫爾特公司 (Beckman Coulter Inc)、豪洛捷公司 (Hologic Inc)、安捷倫科技公司 (Agilent Technologies Inc)、BioGenex Laboratories Inc、Diapath SpA、Bio SB、默克公司 (Merck KGaA Holdings) 和 PHCK Holdings) 等。這些公司正在採取各種策略，包括擴張、產品創新和併購，以增強其產品線並提升其市場佔有率。

In the Asia Pacific region, key players in the anatomic pathology market include China, Japan, India, Australia, and South Korea, with additional insights into other countries in the area. The growth of the anatomic pathology market in this region is primarily driven by the increasing prevalence of chronic diseases and the adoption of digital solutions and advanced pathology tools. Countries like Australia and South Korea are expected to present substantial growth opportunities due to their continuously evolving healthcare systems.

Market Segmentation Analysis

The Asia Pacific anatomic pathology market can be segmented based on products and services, applications, and end users.

1. Products and Services: This segment includes services, instruments, and consumables. In 2023, instruments accounted for the largest market share. The services segment is further divided into histopathology and cytopathology, while the instruments segment includes microtomes, cryostats, automatic stainers, tissue processors, and other related tools.

2. Applications: The market is categorized into disease diagnosis, drug discovery and development, among others. The disease diagnosis segment held the largest share in 2023, reflecting the critical role of anatomic pathology in identifying various health conditions.

3. End Users: This segment includes hospitals, research laboratories, diagnostic laboratories, and others. Hospitals represented the largest share of the market in 2023, highlighting their central role in utilizing anatomic pathology services.

Market Outlook for Asia Pacific Anatomic Pathology

Digital pathology is an emerging area within anatomic pathology that leverages digital technologies to enhance data collection and management processes. This innovation minimizes risks associated with specimen handling and has the potential to expedite patient enrollment in clinical trials. Furthermore, digital pathology can significantly reduce the turnaround time from sample collection to results, thereby streamlining the central pathology review process and improving trial efficiency.

The integration of machine learning (ML) and artificial intelligence (AI) into digital pathology is transforming the field by enhancing data analysis and management capabilities. Many anatomic pathology laboratories are increasingly recognizing the advantages of digitization and AI, which are expected to improve diagnostic accuracy, efficiency, and consistency. Recent technological advancements and regulatory approvals are further promoting the digitalization of laboratory operations.

In November 2023, Dedalus Group and Ibex Medical Analytics introduced a comprehensive AI-powered Digital Pathology Solution aimed at cancer diagnostics. This solution facilitates the complete digitization of anatomic pathology laboratories through a next-generation Anatomic Pathology Information System (AIS) and digital pathology solution, utilizing data and AI for improved case prioritization, advanced image analysis, and consistent diagnoses. The growing emphasis on AI integration in anatomic pathology processes is anticipated to be a significant trend that will drive market growth in the coming years.

Country Insights in the Asia Pacific Anatomic Pathology Market

The Asia Pacific anatomic pathology market includes countries such as China, Japan, India, Australia, South Korea, and others. In 2023, China held the largest market share. Cancer has become a major public health issue in China, with the World Health Organization (WHO) reporting 4.57 million new cancer cases and 3.00 million cancer-related deaths in 2020, the highest globally. This alarming trend has led to a heightened focus on early cancer screening, diagnosis, and treatment.

Over the past two decades, the Chinese government has implemented several large-scale cancer screening initiatives, such as the "Cancer Screening Program in Rural Areas" and the "Cervical Cancer and Breast Cancer Screening Program for Women in Rural Areas." These programs have significantly increased the rate of population-wide screenings for various cancers, contributing to better cancer prevention and control at primary healthcare facilities.

Moreover, China is transitioning from traditional pathological diagnosis methods to digital pathology. According to a 2022 report by the Shanghai Digital Medicine Innovation Center, approximately 40% of surveyed hospitals are either developing or have already established digital pathology systems. Many of these hospitals have invested substantial amounts in these systems, indicating a strong commitment to enhancing their diagnostic capabilities. The report also noted that around 23% of remote clinical consultations utilized digital pathology in 2022, reflecting its growing importance in the healthcare landscape.

Key Players in the Asia Pacific Anatomic Pathology Market

Prominent companies in the anatomic pathology market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others. These companies are pursuing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Asia Pacific Anatomic Pathology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.1.2 Rise in Number of Strategic Initiatives
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
- 5.2.2 Stringent Government Regulations
5.3 Market Opportunities
- 5.3.1 Growing Focus on Personalized Medicines
5.4 Future Trends
- 5.4.1 Integration of Artificial Intelligence and Machine Learning
5.5 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - Asia Pacific Analysis

6.1 Asia Pacific Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 Asia Pacific Anatomic Pathology Market Forecast Analysis

7. Asia Pacific Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Anatomic Pathology Market - Country Analysis

10.1 Asia Pacific
- 10.1.1 Asia Pacific Anatomic Pathology Market Overview
- 10.1.2 Asia Pacific Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 China: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.1.1.1 China: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.1.1.2 China: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.1.2 China: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.1.3 China: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.2 Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.2.1.1 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.2.1.2 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.2.2 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.2.3 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.3 India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 India: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.3.1.1 India: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.3.1.2 India: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.3.2 India: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.3.3 India: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.4 Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.4.1.1 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.4.1.2 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.4.2 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.4.3 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.5 South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.5.1 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.5.1.1 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.5.1.2 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.5.2 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.5.3 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.6 Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.6.1 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.6.1.1 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.6.1.2 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.6.2 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.6.3 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Asia Pacific Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BioGenex Laboratories Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Diapath S.p.A.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio SB
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Merck KGaA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 PHC Holdings Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Anatomic Pathology Market Segmentation
Table 2. Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Product and Services
Table 4. Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 7. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 8. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 9. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 11. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 12. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 13. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 14. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 16. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 17. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 18. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 19. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 20. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 21. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 22. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 23. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 24. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 25. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 26. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 27. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 28. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 29. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 30. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 31. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 32. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 33. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 34. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 35. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 36. Recent Organic Growth Strategies in Asia Pacific Anatomic Pathology Market
Table 37. Recent Inorganic Growth Strategies in the Asia Pacific Anatomic Pathology Market
Table 38. Glossary of Terms, Asia Pacific Anatomic Pathology Market

List Of Figures

Figure 1. Asia Pacific Anatomic Pathology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Asia Pacific Anatomic Pathology Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Anatomic Pathology Market Revenue (US$ Million), 2021-2031
Figure 6. Asia Pacific Anatomic Pathology Market Share (%) - by Product and Services (2023 and 2031)
Figure 7. Services: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Instruments: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Consumables: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Asia Pacific Anatomic Pathology Market Share (%) - by Application (2023 and 2031)
Figure 11. Disease Diagnosis: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Drug Discovery and Development: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Asia Pacific Anatomic Pathology Market Share (%) - by End User (2023 and 2031)
Figure 15. Hospitals: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Research Laboratories: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Others: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Asia Pacific Anatomic Pathology Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
Figure 20. Asia Pacific Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Growth Strategies in Asia Pacific Anatomic Pathology Market